Automate routine blood tests

A Siemens Healthcare Diagnostics product story

Edited by the Laboratorytalk editorial team Jul 23, 2004

Random access haematology analyser enhances laboratory productivity by automating many of the most labour-intensive blood tests routinely requested by clinicians

Bayer Diagnostics has launched a new random access haematology analyser - the Advia 2120 - which enhances laboratory productivity by automating many of the most labour-intensive blood tests routinely requested by clinicians.

The Advia 2120 builds on the proven performance of the Advia 120 haematology system (of which there are now over 3200 in use worldwide), automating full blood counts and reticulocyte monitoring as well as cerebrospinal fluid (CSF) analysis.

Combining 'real world' convenience with high throughput productivity, it is designed to deliver results which are 'right first time every time', potentially reducing film review rates by more than 50%.

The system includes a unique range of advanced clinical parameters as standard, designed to enhance standards of patient care for optimal disease management.

These include reticulocyte haemoglobin content (CHr) and an environmentally-friendly cyanide free haemoglobin method.

A facility for the enumeration of nucleated red blood cells (NRBC) will be available for the system post-launch, while optional multi-species software will also be available for veterinary and research applications.

The Advia 2120 can be integrated with Bayer's Advia CentraLink data management network system, thus enhancing process efficiency.

An integrated track-free connection to the Advia AutoSlide slide-maker stainer will also be available as an upgrade, providing a convenient facility for safe, efficient reflex slide-making.

"The Advia 2120 has been designed to reduce manual test procedures and costly repeats, minimising sample size and workspace requirements while maximising laboratory resources", says Bayer's haematology marketing manager, Sue Mead.

"Innovations such as internal verification on every sample, by which results are compared using two different methodologies, enable users to have total confidence in the results obtained.

Such features provide a unique degree of quality control not seen in other routine haematology analysers, aiding clinicians in the diagnosis and treatment of various disorders such as leukaemia, platelet anomalies and red cell abnormalities.".